Bluebird bio will be acquired by investment firms Carlyle and SK Capital Partners, marking the end to its turbulent time as a ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

A pair of investors will acquire bluebird bio in a deal worth only $29 million upfront after the gene therapy maker ran out ...

By Sneha S K (Reuters) -Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital ...

The referred specimen of the enantiornithine bird Shangyang sp. (IVPP V 26899) was recovered near La-Ma-Dong Village in Jian-Chang County, within the Jiufotang Formation (dated ∼120 Ma). It can be ...

Blue Bird Corporation (BLBD) recently announced fiscal Q1 results, beating top and bottom-line expectations. While the ...

BLBD remains volatile despite strong earnings, federal funding uncertainties, and revised EV sales guidance. Explore more ...

Self-care is important for everyone to prioritize mental, emotional and physical well-being. It includes doing something you ...

Blue Bird experienced a slight topline contraction due to a decrease in EV share in total volumes during Q1. See why I rate BLBD stock a buy.

(CNN) — New York Gov. Kathy Hochul announced the state is temporarily shutting down all live bird markets in New York City and Westchester, Nassau and Suffolk Counties through February 14 after ...

Blue Bird (NASDAQ:BLBD) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...